Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor, Adult × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 22 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Advanced Solid Tumors 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Advanced Solid Tumour 4 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Myeloproliferative Disorders 3 Multiple Myeloma 3 Breast Neoplasms 3 Biliary Tract Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Advanced Malignant Solid Tumor 2 mCRPC (Metastatic Castration-resistant Prostate Cancer) 1 Uterine Cervical Neoplasms 1 Unresectable Locally Recurrent Breast Cancer 1 Tuberous Sclerosis 1

Interventions

pembrolizumab 3 osimertinib 1 leronlimab 1 amivantamab 1 Valganciclovir 1 Radiotherapy 1 Proton Therapy 1 Paclitaxel 1 Lacteol 1 Docetaxel 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡